🇺🇸 FDA
Patent

US 9133133

2,4-pyridinediamine compounds and their uses

granted A61KA61K31/505A61K31/506

Quick answer

US patent 9133133 (2,4-pyridinediamine compounds and their uses) held by Rigel Pharmaceuticals, Inc. expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/505, A61K31/506, A61K31/519, A61K31/5377